Chemed (CHE) Q1 2026 Earnings Call Transcript
Chemed (CHE) reported Q1 2026 earnings with VITAS HealthCare showing a 6.9% increase in admissions and a 3.1% rise in net revenue. However, Roto-Rooter faced declines in both commercial and residential revenue, with adjusted EBITDA down 9.6%. The results highlight mixed performance across the company's segments.
Topics: admissions earnings EBITDA revenue Roto-Rooter VITAS HealthCare